';
Last March, the Departments of Drug and Alcohol Programs (DDAP) and Community & Economic Development (DCED) announced the availability of more than $1 million in grant funding for recovery houses to provide safe housing for individuals in recovery from a substance use disorder (SUD). The grants, funded through the $1.2 million awarded to Pennsylvania through the SUPPORT Act from the U.S. Department of Housing and Urban Development (HUD), are designed to assist existing recovery house facilities with physical upgrades to comply with all federal, state, and local laws and ordinances, including the Americans With Disabilities Act of 1990, which is needed to receive a recovery house license through DDAP.
The federal government requires DCED to annually report on the performance of the state’s Recovery Housing Program. The annual report can be found on the DDAP website.
Comments on the Recovery Housing Program Annual Performance Report may be emailed to David Grey, Chief of Compliance, Center for Community and Housing Development. Comments will also be accepted by telephone by calling 717-787-5327 or through written comments submitted to:
David Grey
Center for Community and Housing Development, Department of Community and Economic Development
400 North Street, 4th Floor, Commonwealth Keystone Building
Harrisburg, PA 17120-0225
All comments must be received by 12:00 pm October 30, 2022.
For more information about this comment period, email David Grey or call 717-787-5327. For more information on this funding opportunity and to apply visit Funding Opportunities.

Up to $20,000 in debt relief is available to those who received a Federal Pell Grant in college and meet the income requirements. Up to $10,000 in debt relief is available to those who received a Federal Pell Grant in college and meet the income requirements.
The U.S. Department of Education is providing this one-time debt relief as part of the Biden-Harris Administration student debt relief plan.
Apply for student debt relief, or get more information at Federal Student Aid.

Registration is open for the fourth annual virtual psychostimulant symposium, “Overcoming Barriers & Making a Difference.” The symposium will be held Wednesday and Thursday, December 7–8, 2022.
Pennsylvania continues to see a rise in stimulant misuse. However, data continues to show that polysubstance use has increased among individuals with a substance use disorder (SUD), as well. The symposium will use data to tell the story of what is happening across the state and nationwide. In addition, it will focus on addressing current issues that prevent individuals from seeking treatment or maintaining their recovery, barriers to treatment, and strategies to help them while making a difference in Pennsylvania’s communities. The goal of the symposium is to educate and provide resources to attendees to assist in their work to help Pennsylvanians suffering from SUD.
Attendance is free, but registration is required. Register today.
Call 610-494-8044 or email registration with questions.
The Office of Mental Health and Substance Abuse Services (OMHSAS) is pleased to share the Pennsylvania Behavioral Health Telehealth Phase II Roadmap, which was developed in collaboration with the OMHSAS Telehealth Steering Committee and Mercer Government Services Consulting. This report focuses on identifying and prioritizing recommendations for short-term and long-term implementation of telehealth services in the Commonwealth. The roadmap includes example documents developed by the Steering Committee that can be used and personalized by the provider when implementing telehealth services. The work of the Steering Committee and other stakeholders has been and will continue to be vital in ensuring that the behavioral health needs of Pennsylvanians continue to be met.
RCPA recommends that your agency reviews the document with your teams as well as compares it to your current policies and practices. These recommendations are not mandates but offer a series of best practices as developed by the Behavioral Health Steering Committee. Additionally, RCPA will conduct an internal review and will request OMHSAS attend the next Telehealth Committee Meeting.
If you have questions regarding this report, please email OMHSAS and/or RCPA Policy Director Jim Sharp.
The open enrollment period for substance use disorder (SUD) treatment providers licensed by the Pennsylvania Department of Drug and Alcohol Programs (DDAP) to submit their information to be included in the Addiction Treatment Locator, Assessment, and Standards Platform (ATLAS) has begun and will continue through December 30, 2022.
Provider participation in ATLAS is voluntary. Facilities already included in ATLAS that need to update any of their information can do so during the open enrollment period and should contact Shatterproof directly.
Facilities that have not submitted the treatment facility survey can complete it during the open enrollment period to have their information appear in ATLAS. Shatterproof will reach out directly to licensed SUD facilities not currently included on ATLAS. There is a streamlined submission process for organizations with multiple facilities.
By completing the ATLAS survey during the 2022 open enrollment period, treatment facilities ensure that the information presented in their site’s profile on TreatmentATLAS.org is accurate. Providers also gain access to a customized portal that allows them to benchmark and compare their services against their peers.